Kyverna Therapeutics, Inc.

KYTX·NASDAQ·$8.61Share Price as of 11/2·$377MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report09/24/26 8-KCurrent report08/11/26 8-KCurrent report07/27/26 8-KCurrent report07/09/26 8-KCurrent report06/02/26

Prospectuses and Registrations

424B5Prospectus supplement04/02/26 S-3Shelf registration03/26/26 S-8Registration of securities for employees03/26/26 424B5Prospectus supplement12/18/25 FWPFree writing prospectus12/17/25

Proxies

DEF 14ADefinitive proxy04/13/26 DEFA14AAdditional proxy materials04/13/26 DEF 14ADefinitive proxy04/14/25 DEFA14AAdditional proxy materials04/14/25

Ownership

SC 13GBeneficial ownership10/19/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13GBeneficial ownership07/29/26 Form 4Insider transaction05/29/26 Form 4Insider transaction05/29/26

Other

ARSAnnual report to shareholders04/13/26 EFFECTRequest for effectiveness04/02/26 CORRESPCorrespondence with the SEC03/31/26 UPLOADLetter from the SEC03/30/26 EFFECTRequest for effectiveness04/15/25